Search Orphan Drug Designations and Approvals
-
Generic Name: | rituximab |
---|---|
Date Designated: | 03/12/2002 |
Orphan Designation: | Treatment of immune thrombocytopenic purpura |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Genentech, Inc. 1 DNA Way South San Francisco, California 94080 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
-